Guide GLP-1 & Telehealth

What are GLP-1 receptor agonist medicines?

A neutral overview of prescription GLP-1 medicines, legitimate access, product-specific approval, monitoring and limits of online guidance.

Information only — not medical advice. We separate consumer guidance from treatment decisions and make no disease-cure claims for supplements. Spotted an error? Tell us — see our corrections policy.

Key facts

Status Prescription-only medicine; approval and indication depend on the named product and market
Assessment Medical history, other medicines, contraindications and follow-up require a qualified prescriber
Online access A consultation channel, not a substitute for clinical assessment

Step by step

  1. Identify the exact medicine, approved indication and regulator-authorized product information for your market.
  2. Confirm that a qualified prescriber assesses medical history, current medicines and suitability.
  3. Ask how follow-up, adverse effects, storage, supply and stopping treatment will be handled.

“GLP-1” describes a biological pathway and a medicine class; it is not one single product. Consumer decisions must start with the exact medicine, market and approved indication.

What does the medicine class do?

GLP-1 receptor agonists act on receptors involved in glucose regulation, digestion and appetite. That general description does not predict what a particular person will experience. Each authorized medicine has product-specific indications, contraindications, dosing instructions, warnings and adverse effects.

The NIDDK overview of prescription weight-management medicines describes prescription treatments and their limits. Follow the FDA-authorized patient information for the exact product and indication.

What should legitimate online access include?

Telehealth can move a consultation online; it does not remove the prescriber, pharmacy or safety process. A legitimate pathway should make clear:

  • which qualified professional assesses the patient;
  • which licensed pharmacy supplies the medicine;
  • how medical history and other medicines are considered;
  • how questions, follow-up and adverse effects are handled;
  • the total recurring cost and what happens if supply changes.

In the US, FDA advises consumers to obtain a prescription from a licensed healthcare provider and fill it at a state-licensed pharmacy.

Why does the exact product matter?

Approval does not transfer from one active ingredient, formulation or indication to another. Nor does an approval mean a medicine is suitable for everyone. Avoid language such as “FDA-approved GLP-1” without naming the product and its approved use.

Compounded products require a separate discussion. FDA states that compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before marketing. They should not be described as interchangeable with an approved product merely because a seller uses the same class name.

What are the limits of this guide?

This page does not list eligibility rules, choose a medicine, recommend a dose, or interpret symptoms. Those are clinical tasks. Bring the exact product name, your full medicine list and your questions to a qualified prescriber or pharmacist. This article has official sources but still awaits qualified human clinical review, as the status box states.

Frequently asked

Are all GLP-1 medicines approved for weight management?
No. Approved indications are medicine- and market-specific. Not all GLP-1 medicines have an FDA-approved weight-management indication. Check the exact product's regulator-authorized information.
Can an online questionnaire guarantee that a GLP-1 is suitable?
No. A questionnaire may collect information, but suitability, prescribing and monitoring are clinical decisions. Confirm who reviews the information and how you can contact the prescriber or pharmacy.

Want this matched to your goal?

Ask the Sherpa to compare supplied regulator, certification and subscription fields — then verify them independently.

Ask the Sherpa

Sources

Official or primary sources used for this page. Access dates show when the editorial desk last checked each page; they do not replace current clinical advice.

  1. Prescription Medications to Treat Overweight and Obesity National Institute of Diabetes and Digestive and Kidney Diseases · accessed
  2. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss U.S. Food and Drug Administration · accessed